DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Drotaverine is an investigational drug.
There have been 6 clinical trials for Drotaverine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Asphyxia Neonatorum, Asphyxia, and Pancreatic Diseases. The leading clinical trial sponsors are eran ashwal, Ain Shams Maternity Hospital, and Ain Shams University.
Recent Clinical Trials for Drotaverine
|Morphine Versus Ketorolac in Renal Colic||Loredana Ghinea||Phase 4|
|The Impact of Papaverine on First Stage of Labor||eran ashwal||Phase 3|
|Drotaverine to Shorten the Length of Labor||Ain Shams Maternity Hospital||Phase 2/Phase 3|